Changing incidence and improved survival of gliomas

European Journal of Cancer

Volumn 50, Issue 13, 2014, Pages 2309-2318

  Ho, Vincent K Y ^a   Reijneveld, Jaap C ^b   Enting, Roelien H ^c   Bienfait, Henri P ^d   Robe, Pierre ^e   Baumert, Brigitta G ^f,g   Visser, Otto ^a  

^a Department of Cancer Registry and Research   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d GELRE HOSPITALS   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF BONN   (Germany)

Author keywords

Astrocytoma; Central nervous system; Ependymoma; Glioblastoma; Glioma; Incidence; Oligoastrocytoma; Oligodendroglioma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANAPLASTIC EPENDYMOMA; ANAPLASTIC OLIGOASTROCYTOMA; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DIFFUSE ASTROCYTOMA; EPENDYMOMA; FEMALE; GLIOBLASTOMA; GLIOMATOSIS CEREBRI; GLIOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NETHERLANDS; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PLEIOMORPHIC XANTHOASTROCYTOMA; PRIORITY JOURNAL; SURVIVAL RATE; TIME; TUMOR BIOPSY; BRAIN NEOPLASMS; EPIDEMIOLOGY; GLIOMA; INCIDENCE; MIDDLE AGED; MORTALITY; PATHOLOGY; SPINAL CORD NEOPLASMS;

AGED; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; SPINAL CORD NEOPLASMS; SURVIVAL RATE;

EID: 84905127102     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.05.019     Document Type: Article

References (43)

1. Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006; 2010.
2. B.A. Kohler, E. Ward, B.J. McCarthy, M.J. Schymura, L.A. Ries, and C. Eheman et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system J Natl Cancer Inst 103 9 2011 714 736
3. E. Crocetti, A. Trama, C. Stiller, A. Caldarella, R. Soffietti, and J. Jaal et al. Epidemiology of glial and non-glial brain tumours in Europe Eur J Cancer 48 10 2012 1532 1542
4. D.N. Louis, H. Ohgaki, O.D. Wiestler, and W.K. Cavanee WHO classification of tumours of the central nervous system 4th ed. 2007 IARC Press Lyon
5. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 2005 987 996
6. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, and R.C. Janzer et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 5 2009 459 466
7. I.R. Whittle The dilemma of low grade glioma J Neurol Neurosurg Psychiatry 75 Suppl. 2 2004 ii31 ii36
8. V.C. Prabhu, A. Khaldi, K.P. Barton, E. Melian, M.J. Schneck, and M.J. Primeau et al. Management of diffuse low-grade cerebral gliomas Neurol Clin 28 4 2010 1037 1059
9. F.F. Lang, and M.R. Gilbert Diffusely infiltrative low-grade gliomas in adults J Clin Oncol 24 8 2006 1236 1245
10. D. Schiff, P.D. Brown, and C. Giannini Outcome in adult low-grade glioma: the impact of prognostic factors and treatment Neurology 69 13 2007 1366 1373
11. L.D. Recht, R. Lew, and T.W. Smith Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31 4 1992 431 436
12. J.C. Reijneveld, M.M. Sitskoorn, M. Klein, J. Nuyen, and M.J. Taphoorn Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas Neurology 56 5 2001 618 623
13. M.L. van Veelen, C.J. Avezaat, J.M. Kros, W. van Putten, and C. Vecht Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery J Neurol Neurosurg Psychiatry 64 5 1998 581 587
14. M.J. van den Bent, T.J. Snijders, and J.E. Bromberg Current treatment of low grade gliomas Memo 5 3 2012 223 227
15. R. Soffietti, B.G. Baumert, L. Bello, A. von Deimling, H. Duffau, and M. Frenay et al. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force Eur J Neurol 17 9 2010 1124 1133
16. A.S. Jakola, K.S. Myrmel, R. Kloster, S.H. Torp, S. Lindal, and G. Unsgard et al. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas JAMA 308 18 2012 1881 1888
17. A.P. Polednak, and J.T. Flannery Brain, other central nervous system, and eye cancer Cancer 75 1 Suppl. 1995 330 337
18. M.H. Werner, S. Phuphanich, and G.H. Lyman The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly Cancer 76 9 1995 1634 1642
19. A. Helseth The incidence of primary central nervous system neoplasms before and after computerized tomography availability J Neurosurg 83 6 1995 999 1003
20. Z. Morris, W.N. Whiteley, W.T. Longstreth Jr, F. Weber, Y.C. Lee, and Y. Tsushima et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis BMJ 17 339 2009 b3016
21. J.M. Legler, L.A. Ries, M.A. Smith, J.L. Warren, E.F. Heineman, and R.S. Kaplan et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality J Natl Cancer Inst 91 16 1999 1382 1390
22. M.P. Houben, K.K. Aben, J.L. Teepen, A.Y. Schouten-Van Meeteren, C.C. Tijssen, and C.M. Van Duijn et al. Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003 Acta Oncol 45 3 2006 272 279
23. J.G. Gurney, and N. Kadan-Lottick Brain and other central nervous system tumors: rates, trends, and epidemiology Curr Opin Oncol 13 3 2001 160 166
24. H. Ahsan, A.I. Neugut, and J.N. Bruce Trends in incidence of primary malignant brain tumors in USA, 1981-1990 Int J Epidemiol 24 6 1995 1078 1085
25. T.B. Johannesen, E. Angell-Andersen, S. Tretli, F. Langmark, and K. Lote Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999 Neuroepidemiology 23 3 2004 101 109
26. S. Lonn, L. Klaeboe, P. Hall, T. Mathiesen, A. Auvinen, and H.C. Christensen et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries Int J Cancer 108 3 2004 450 455
27. S. Hoffman, J.M. Propp, and B.J. McCarthy Temporal trends in incidence of primary brain tumors in the United States, 1985-1999 Neuro Oncol 8 1 2006 27 37
28. J.M. Kros Grading of gliomas: the road from eminence to evidence J Neuropathol Exp Neurol 70 2 2011 101 109
29. L.J. Schouten, P. Hoppener, P.A. van den Brandt, J.A. Knottnerus, and J.J. Jager Completeness of cancer registration in Limburg, The Netherlands Int J Epidemiol 22 3 1993 369 376
30. J. Berkel General practitioners and completeness of cancer registry J Epidemiol Community Health 44 2 1990 121 124
31. G.A. van der Sanden, P. Wesseling, L.J. Schouten, H.L. Teepen, and J. Coebergh A uniform histological cluster scheme for ICD-O-coded primary central nervous system tumors Neuroepidemiology 17 5 1998 233 246
32. L.E. Levesque, J.A. Hanley, A. Kezouh, and S. Suissa Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes BMJ 12 340 2010 b5087
33. A. Wohrer, T. Waldhor, H. Heinzl, M. Hackl, J. Feichtinger, and U. Gruber-Mosenbacher et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry J Neurooncol 95 3 2009 401 411
34. H. Ohgaki, and P. Kleihues Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 64 6 2005 479 489
35. M.E. Hegi, A.C. Diserens, T. Gorlia, M.F. Hamou, N. de Tribolet, and M. Weller et al. MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 10 2005 997 1003
36. A. Malmstrom, B.H. Gronberg, C. Marosi, R. Stupp, D. Frappaz, and H. Schultz et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Lancet Oncol 13 9 2012 916 926
37. W. Wick, M. Platten, C. Meisner, J. Felsberg, G. Tabatabai, and M. Simon et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Lancet Oncol 13 7 2012 707 715
38. M.J. van den Bent, A.A. Brandes, M.J. Taphoorn, J.M. Kros, M.C. Kouwenhoven, and J.Y. Delattre et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 J Clin Oncol 31 3 2013 344 350
39. C.E. Pelloski, K.V. Ballman, A.F. Furth, L. Zhang, E. Lin, and E.P. Sulman et al. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma J Clin Oncol 25 16 2007 2288 2294
40. H.S. Phillips, S. Kharbanda, R. Chen, W.F. Forrest, R.H. Soriano, and T.D. Wu et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 3 2006 157 173
41. C.L. Nutt, D.R. Mani, R.A. Betensky, P. Tamayo, J.G. Cairncross, and C. Ladd et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification Cancer Res 63 7 2003 1602 1607
42. F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, and A. Stegh et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes Dev 21 21 2007 2683 2710
43. H. Ohgaki, and P. Kleihues The definition of primary and secondary glioblastoma Clin Cancer Res 19 4 2013 764 772